Sakar Healthcare Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

303.55

-3.50 (-1.14%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

303.55

-3.50 (-1.14%)
15:43 Dec 20

Quality

66/100
High Financial Strength

Valuation

37/100
Mid Valuation

Technical

42/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	94.74	128.23	133.36	153.35	164.22
Operating Expenses +	72.14	98.9	100.21	114.99	122.04
Raw Material	0	0	0	0	91.12
Increase Decrease in Cost	-0.91	0.93	-0.36	-1.38	-0.52
Other Manufacturing Expense	52.02	73.49	73.9	85.05	0
Employee Cost	13.26	15.22	16.77	19.78	20.55
Miscellaneous Expenses	7.77	9.26	9.9	11.54	10.89
Operating Profit	22.6	29.33	33.15	38.36	42.18
Other Income	1.18	2.17	4.67	3.18	1.83
Depreciation	8.06	9.67	14.99	18.05	19.49
Interest	2.48	2.9	5.95	7.59	6.91
Profit before tax and exceptio..	13.23	18.93	16.88	15.9	17.61
Exceptional Items	0	0	0	0	0
PBT	13.23	18.93	16.88	15.9	17.61
Provision for Taxation	2.55	3.75	4.12	4.23	5.2
Net Profit	10.68	15.18	12.76	11.67	12.4
NET Profit after MI	10.68	15.18	12.76	11.67	12.4
EPS	6.84	8.73	6.75	5.63	5.71
Operating Profit Margin (%)	23.85	22.87	24.86	25.01	25.69
Net Profit Margin (%)	11.27	11.84	9.57	7.61	7.55

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	53.20	53.20	53.20	53.20	54.20
FII	13.40	13.50	13.50	13.80	14.00
MF	0.00	0.00	0.00	0.00	0.00
Public	22.80	22.70	22.70	22.50	21.00
Others	0.00	0.00	0.00	0.00	0.00
Others	10.60	10.60	10.60	10.50	10.80